Search - tctmd.com

Displaying 421 - 435 of 435

Sort: Relevancy | Date

News Daily News

High BP While Lying Down Signals Future CVD Risk

Todd Neale

January 22, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

CMS Opens Coverage Analysis for Renal Denervation

Todd Neale

January 14, 2025

News Daily News

J&J Halts Varipulse Pulsed-Field Ablation Cases in the US

Todd Neale

January 08, 2025

News Daily News

FDA Issues Draft Guidance for Improving Skin Tone Disparities of Pulse Oximeters

L.A. McKeown

January 08, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

Presentation Cardiovascular Interventions 2024

AGENT DCB: Device and Data

Presenter: Paul S. Teirstein

November 11, 2024

Presentation Cardiovascular Interventions 2024

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Presenter: Matthew J. Price

November 11, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Video

» Live Case

Live Case 17- TTVR and AI Enabled M-TEER Device Guidance_Live Pre-Recorded Case Presentation 2- AI Enabled Image Guidance for Mitral TEER (PASCAL) - New York Presbyterian Hospital-Columbia University, New York, NY

July 2, 2025

Video

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

March 5, 2025

Partner Content

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

March 5, 2025

CME

Advertisement

High BP While Lying Down Signals Future CVD Risk

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

CMS Opens Coverage Analysis for Renal Denervation

J&J Halts Varipulse Pulsed-Field Ablation Cases in the US

FDA Issues Draft Guidance for Improving Skin Tone Disparities of Pulse Oximeters

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

TCTMD’s Biggest News of 2024: Stories, Videos, and More

AGENT DCB: Device and Data

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Live Case 17- TTVR and AI Enabled M-TEER Device Guidance_Live Pre-Recorded Case Presentation 2- AI Enabled Image Guidance for Mitral TEER (PASCAL) - New York Presbyterian Hospital-Columbia University, New York, NY

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

The Role of Atrial Shunts in the Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content